Stereotaxis is a healthcare technology and innovation leader in the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab.
Quote | Stereotaxis Inc. (OTCMKTS:STXS)
Last: | $ |
---|---|
Change Percent: | 7.29% |
Open: | $4.05 |
Close: | $4.27 |
High: | $4.29 |
Low: | $4.017 |
Volume: | 223,019 |
Last Trade Date Time: | 02/12/2020 04:57:08 pm |
News | Stereotaxis Inc. (OTCMKTS:STXS)
ST. LOUIS, July 22, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2024 second quarter on Monday, August 12, 2024 at the close ...
ST. LOUIS, July 18, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced the appointment of Nachum “Homi” Shamir to its Board of Directors. Mr. Shamir most recently served as Chairma...
Message Board Posts | Stereotaxis Inc. (OTCMKTS:STXS)
Subject | By | Source | When |
---|---|---|---|
$STXS MomentumIts now | ALL-IN888 | investorshub | 05/14/2023 1:38:29 PM |
$STXS news all the way baby | tradeologist | investorshub | 05/14/2023 1:49:03 AM |
$STXS Long and strong lets hope im right | manxy | investorshub | 05/12/2023 8:54:45 PM |
bears and bulls | legaltips | investorshub | 05/09/2023 4:11:59 PM |
$STXS news out | legaltips | investorshub | 05/08/2023 11:44:11 AM |
News, Short Squeeze, Breakout and More Instantly...
ST. LOUIS, July 22, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2024 second quarter on Monday, August 12, 2024 at the close ...
ST. LOUIS, July 18, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced the appointment of Nachum “Homi” Shamir to its Board of Directors. Mr. Shamir most recently served as Chairma...
ST. LOUIS, May 29, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announces the successful treatment of the first heart rhythm patients by Penn Presbyterian Medical Center (PPMC) utilizing the advanced Gene...